stage iiic breast cancer
Showing 1 - 25 of 119
Estrogen Receptor Negative, HER2/Neu Negative, Invasive Breast Carcinoma Trial in South Africa, United States (drug, other,
Active, not recruiting
- Estrogen Receptor Negative
- +11 more
- Capecitabine
- +2 more
-
Mobile, Alabama
- +1023 more
Dec 7, 2022
Estrogen Receptor Negative, Estrogen Receptor Positive, HER2/Neu Negative Trial in Bellevue, Grand Island, Omaha (drug, other,
Active, not recruiting
- Estrogen Receptor Negative
- +15 more
- Cyclophosphamide
- +6 more
-
Bellevue, Nebraska
- +3 more
Nov 30, 2022
HER2-positive Breast Cancer, Stage III Ovarian Epithelial Cancer, Stage III Ovarian Germ Cell Tumor Trial in Seattle
Active, not recruiting
- HER2-positive Breast Cancer
- +8 more
- pNGVL3-hICD vaccine
- +6 more
-
Seattle, WashingtonFred Hutchinson Cancer Research Center/University of Washington
Nov 1, 2022
Stage IA Breast Cancer, Stage IB Breast Cancer, Stage IIA Breast Cancer Trial in United States (Telephone-Based Intervention,
Recruiting
- Stage IA Breast Cancer
- +7 more
- Telephone-Based Intervention
- +2 more
-
Goldsboro, North Carolina
- +3 more
Oct 27, 2022
HER2 Positive Breast Carcinoma, Recurrent Breast Carcinoma, Stage III Breast Cancer Trial in Palo Alto (Utomilumab, Trastuzumab,
Completed
- HER2 Positive Breast Carcinoma
- +6 more
- Utomilumab
- +2 more
-
Palo Alto, CaliforniaStanford University, School of Medicine
Sep 22, 2022
Estrogen Receptor Positive, HER2/Neu Negative, Invasive Breast Carcinoma Trial in Los Angeles (procedure, drug, other)
Terminated
- Estrogen Receptor Positive
- +16 more
- Biopsy of Breast
- +5 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Sep 22, 2022
Estrogen Receptor-positive Breast Cancer, Musculoskeletal Complications, Progesterone Receptor-positive Breast Cancer Trial in
Active, not recruiting
- Estrogen Receptor-positive Breast Cancer
- +9 more
- anastrozole
- +3 more
-
Boston, Massachusetts
- +1 more
Sep 9, 2022
Cancer Survivor, Early-Stage Breast Carcinoma, Stage 0 Breast Cancer Trial in Los Angeles, Baltimore, Boston (Educational
Active, not recruiting
- Cancer Survivor
- +9 more
- Educational Intervention
- +3 more
-
Los Angeles, California
- +2 more
Jul 18, 2022
Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer Trial in
Terminated
- Estrogen Receptor-positive Breast Cancer
- +7 more
- everolimus
- +5 more
-
Atlanta, Georgia
- +2 more
Mar 10, 2022
Obesity, Stage IA Breast Cancer, Stage IB Breast Cancer Trial in Duarte (Dietary Intervention, Educational Intervention,
Active, not recruiting
- Obesity
- +7 more
- Dietary Intervention
- +3 more
-
Duarte, CaliforniaCity of Hope Medical Center
Mar 17, 2022
HER2-positive Breast Cancer, Recurrent Breast Cancer, Stage IIA Breast Cancer Trial in Duarte, Lancaster, South Pasadena
Active, not recruiting
- HER2-positive Breast Cancer
- +9 more
- pertuzumab
- +3 more
-
Duarte, California
- +2 more
Mar 17, 2022
Solid Tumor, Stage III Pancreatic Cancer, Stage IIIA Breast Cancer Trial in Atlanta (Carboplatin, Cisplatin, Palbociclib)
Active, not recruiting
- Solid Neoplasm
- +16 more
- Carboplatin
- +2 more
-
Atlanta, GeorgiaEmory University/Winship Cancer Institute
Feb 28, 2022
Cancer Survivor, Stage 0 Breast Cancer, Stage IA Breast Cancer Trial in Columbus (Educational Intervention, Exercise
Completed
- Cancer Survivor
- +8 more
- Educational Intervention
- +3 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Feb 23, 2022
HER2 Negative Breast Carcinoma, Recurrent Breast Carcinoma, Stage IIIA Breast Cancer Trial in Seattle
Recruiting
- HER2 Negative Breast Carcinoma
- +6 more
- CD105/Yb-1/SOX2/CDH3/MDM2-polyepitope Plasmid DNA Vaccine
- Laboratory Biomarker Analysis
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Feb 18, 2022
Inflammatory Breast Cancer, Invasive Ductal Breast Carcinoma, Invasive Lobular Breast Carcinoma Trial in New Brunswick, Salt
Active, not recruiting
- Inflammatory Breast Cancer
- +9 more
- External beam radiation therapy
-
New Brunswick, New Jersey
- +1 more
Jan 30, 2022
Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer Trial in Aurora (Omega-3 fatty acid, Celecoxib)
Active, not recruiting
- Stage IA Breast Cancer
- +6 more
- Omega-3 fatty acid
- Celecoxib
-
Aurora, ColoradoUniversity of Colorado Cancer Center
Jan 14, 2022
HER2/Neu Negative, No Evidence of Disease, One or More Positive Axillary Nodes Trial in Seattle, Madison (Laboratory Biomarker
Active, not recruiting
- HER2/Neu Negative
- +10 more
- Laboratory Biomarker Analysis
- +2 more
-
Seattle, Washington
- +1 more
Jan 11, 2022
Benign Breast Tumor, Ductal Breast Carcinoma In Situ, Invasive Breast Carcinoma Trial in Boston, New York, Houston
Completed
- Benign Breast Neoplasm
- +11 more
- Docosahexaenoic Acid
- Placebo
-
Boston, Massachusetts
- +3 more
Dec 3, 2021
Febrile Neutropenia, Stage 0 Breast Cancer, Stage 0 Colorectal Cancer Trial in Puerto Rico, United States (Preventive
Completed
- Febrile Neutropenia
- +27 more
- Preventive Intervention
- +2 more
-
Jonesboro, Arkansas
- +159 more
Dec 22, 2021
Healthy, no Evidence of Disease, Stage II Breast Cancer, Stage IIIA Breast Cancer Trial in Los Angeles (light-scattering
Terminated
- Healthy, no Evidence of Disease
- +4 more
- light-scattering spectroscopy
-
Los Angeles, CaliforniaUSC Norris Comprehensive Cancer Center
Nov 11, 2021
Estrogen Receptor-negative Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-negative Breast Cancer Trial in New
Suspended
- Estrogen Receptor-negative Breast Cancer
- +8 more
- pegylated liposomal doxorubicin hydrochloride
- +6 more
-
New Brunswick, New JerseyRutgers Cancer Institute of New Jersey
Sep 20, 2021
Stage III Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer Trial in Nashville (Atezolizumab, Cobimetinib,
Terminated
- Stage III Breast Cancer
- +6 more
- Atezolizumab
- +2 more
-
Nashville, TennesseeVanderbilt-Ingram Cancer Center
Aug 10, 2021
Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Invasive Ductal Breast Carcinoma Trial in Puerto Rico,
Active, not recruiting
- Estrogen Receptor-positive Breast Cancer
- +8 more
-
Birmingham, Alabama
- +859 more
Jul 19, 2021
Inflammatory Breast Cancer, Stage IIA Breast Cancer, Stage IIIA Breast Cancer Trial in Duarte, South Pasadena (carboplatin,
Active, not recruiting
- Inflammatory Breast Cancer
- +9 more
- carboplatin
- +2 more
-
Duarte, California
- +1 more
Jul 9, 2021